As of May 2022 Hikma Pharmaceuticals has a market cap of $4.83 Billion. This makes Hikma Pharmaceuticals the world's 2293th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2022 | $4.68 B | -32.49% |
2021 | $6.93 B | -12.33% |
2020 | $7.91 B | 25.04% |
2019 | $6.32 B | 20.32% |
2018 | $5.25 B | 43.31% |
2017 | $3.66 B | -34.28% |
2016 | $5.58 B | -18.13% |
2015 | $6.81 B | 11.22% |
2014 | $6.13 B | 56.29% |
2013 | $3.92 B | 61.85% |
2012 | $2.42 B | 29.54% |
2011 | $1.87 B | -21.08% |
2010 | $2.37 B | 47.4% |
2009 | $1.60 B | 76.21% |
2008 | $0.91 B | -41.18% |
2007 | $1.55 B | 32.92% |
2006 | $1.16 B |
On May 15th, 2022 the market cap of Hikma Pharmaceuticals was reported to be: